Alira Health and GDMH together to boost Life Sciences innovation

The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.

Alira Health, a global advisory and clinical research firm with the mission to humanize healthcare and life sciences, announces a new collaboration agreement signed with GDMH – Gemelli Digital Medicine & Health, part of Fondazione Policlinico Agostino Gemelli IRCCS (FPG) and prime provider of turn-key solutions in digital medicine and health in Italy. The goal of this partnership is to develop innovative solutions in the fields of Digital Health, Real-World Evidence (RWE) and Market Access in the best interest of research and patients, while ensuring the highest standards of data quality and protection.

We are thrilled to kick start this partnership with GDMH to accelerate the adoption of patient-centered technologies in our quest to humanize healthcare. We are joining forces with GDMH to build, in partnership with patients, digital health solutions that enable a full spectrum of use cases, including Decentralized Clinical Trials, Patient Support Programs, and DTx for pharma, MedTech, providers, and the payer community. Together GDMH and Alira Health bring a wealth of knowledge in clinical development, health tech, data science, market access, commercial strategy, and RWE.”
Piergiulio Lauriano Chief Strategy Officer at Alira Health
We at GDMH look forward to this collaboration in order to bring our digital solutions closer to the clinical research domain in a pragmatic and efficient way. It will help deepen each party's capabilities and bring lessons and solutions to GDMH, the healthcare and Pharma industries, as well as to the medical community and patients, and possibly to other industry sectors.”
Alfredo Cesario Chief Executive Officer at GDMH
Alira Health and GDMH will collaborate together in the fields of Digital Health, RWE and Market Access to co-develop innovative solutions in the best interests of research and patients. Thanks to this partnership, we will be able to merge our know-how, network, and capabilities, to explore the use of innovative digital health solutions and enable a full spectrum of use cases of joint value for both GDMH and Alira Health.”
Jean-François Ricci Chief Access Officer at Alira Health
About Alira Health

Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.

Learn more:

About GDMH – Gemelli Digital Medicine & Health

Gemelli Digital Medicine & Health (GDMH), a company fully owned by Fondazione Policlinico Gemelli, is a prime integrator and provider of turn-key solutions in Digital Medicine and Health. First movers in the market with the profile of a large general hospital spin off we co-create together with the best players in the Digital Medicine scenario, deploy and manage advanced digital medical solutions worldwide with complete ethical, technical, and legal credentials.

Learn more:

Related news

News March 27, 2023
Alira Health CEO Gabriele Brambilla Interviewed by Investment Reports
Alira Health CEO Gabriele Brambilla recently shared his thoughts on the importance of patient engagement and the digital tools that will allow patients to better manage their own health data and care.
Digital Health Patient Advocacy
News March 27, 2023
Alira Health’s Renee Willmon and MG Registry featured in new Rare Disease Article Series
In the article, “Alira Health and the MGFA Partner to Develop a Myasthenia Gravis Registry,” Renee shares how her professional journey has led her to her current involvement in(...)
Clinical Trials Digital Health Patient Advocacy
Multimedia March 22, 2023
The MedTech World Podcast: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the MedTech World Podcast to discuss his experiences and journey in the Healthcare industry.
Digital Health MedTech
Blog March 20, 2023
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Drug Development Market Access Pharma
Events March 20, 2023
MGFA National Patient Conference 2023
We are pleased to share that we will be participating in MGFA National Patient Conference 2023 as speakers and exhibitors.
Digital Health Innovation Patient Engagement
Blog March 17, 2023
Diversity in Clinical Trials: A Blog Series
How can you successfully engage with patients from diverse populations? To gain the latest insights on the impact, challenges, and strategies, we are pleased to bring you a new series(...)
Clinical Trials Patient Advocacy Patient Engagement
Blog March 16, 2023
How Can Clinical Trials be More Inclusive?
Working with patients and patient leaders early and often can help life science companies to advance the mission of diversifying clinical trials and ultimately, bringing products to(...)
Clinical Trials Patient Advocacy Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.